gms | German Medical Science

16th Annual Meeting of the German Drug Utilisation Research Group (GAA)

Gesellschaft für Arzneimittelforschung und Arzneimittelepidemiologie

19.11. - 20.11.2009, Berlin


Meeting Abstract (09gaa14)

Reporting of safety issues in clinical trials, SUSAR and DSUR

Siegert J, Kosa M, Brecht B, Böhme A, Schröder J, Schindler C, Kirch W
[Full Text]
Meeting Abstract (09gaa15)

Preventability of adverse drug reactions leading to hospital admission – assessment of inter-rater variability within the Network of Regional Pharmacovigilance Centers

Schmiedl S, Szymanski J, Rottenkolber M, Drewelow B, May K, Hippius M, Farker K, Hasford J, Thürmann PA
[Full Text]
Meeting Abstract (09gaa16)

Development and application of an electronic tool for the collection of medication data in pharmacoepidemiological studies

Quinzler R, Zint K, Raum E, Brenner H, Metzner M, Haefeli WE
[Full Text]
Meeting Abstract (09gaa17)

Medication review of patients community-dwelling seniors using high-level homecare service

Ermer M, Harder S
[Full Text]
Meeting Abstract (09gaa18)

How are asthma types coded in the out-patient sector? Analysis of claims data from 2004–2007

Windt R, Glaeske G
[Full Text]
Meeting Abstract (09gaa19)

Is there a correlation between hormone therapy and the prescription of antidepressants?

Gerdau-Heitmann C, Glaeske G, Janhsen K
[Full Text]
Meeting Abstract (09gaa20)

Prescription patterns of drugs inhibiting the renin-angiotensin-aldosterone-system (RAAS) in the Federal State of Saxony – an analysis of the AOK health insurance service database in the years 2003 and 2004

Kosa M, Siegert J, Brecht B, Schröder J, Maywald U, Kirch W, Schindler C
[Full Text]
Meeting Abstract (09gaa21)

Prescription of antidepressants and comorbidity of depression

Schicktanz C, Glaeske G, Janhsen K
[Full Text]
Meeting Abstract (09gaa22)

Private prescriptions of zolpidem and zopiclone: What medication claims data won't tell us

Hoffmann F, Glaeske G
[Full Text]
Meeting Abstract (09gaa23)

Insulin glargin stellt eine kostengünstige Alternative im Vergleich zu NPH-Insulin bei der Behandlung insulinpflichtiger Diabetiker dar: Ergebnisse einer Verordnungsdatenanalyse

Dippel FW, Schneider T, Schöffski O, Ponzel R, Kleinfeld A
[Full Text]
Meeting Abstract (09gaa24)

Resource utilization and treatment costs in type 2 diabetes on intensified insulin therapy with insulin glargine compared to insulin detemir under real world conditions in Germany

Bierwirth RA, Knollmeyer J, Kohlmann T, Holle R
[Full Text]
Meeting Abstract (09gaa25)

Consumption of intranasal corticosteroid-containing sprays (INS) for the treatment of allergic rhinitis – a comparison of "real life" prescription data of treatment with budesonide and mometasone in Germany

Schöffski O, Becker B
[Full Text]
Meeting Abstract (09gaa26)

ATC-based determination of the specialization of Statutory Health Insurance Accredited Physicians

Schuster R.
[Full Text]
Meeting Abstract (09gaa27)

Patient information needs identified by a drug information service

Goltz L, Kosa M, Lochner S, Schröder J, Siegert J, Schindler C, Kirch W
[Full Text]